Skip to content
OpenCapital
Get started

CareTrust CTRE Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Atmos Energy logo
Atmos EnergyATO
$199.62M—
Cherry Hill Mortgage Investment logo
Cherry Hill Mortgage InvestmentCHMI
$165K-95.4%
WEC Energy Group logo
WEC Energy GroupWEC
$12.8M-89.1%
WAT
Waters CorporationWAT
$3M-62.5%
Henry Schein logo
Henry ScheinHSIC
$1M0.0%
RBC Bearings logo
RBC BearingsRBC
$1.13M—

Other financials

Income statement

See full
Revenue$142.8M+47.8%
Gross profit$49.7M—
Net income$80.2M+21.9%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$223.2M-64.7%
Total debt$894.6M+8.8%
Total equity$4.1B+41.1%
Total assets$5.2B+34.8%

Cash flow

See full
Operating cash flow$90.4M+26.6%
CapEx$440.3K—
Free cash flow$98.1M+60.6%

Valuation

See full
Market cap$8.76B+52.5%
Enterprise value$9.43B+59.4%
P/E26.1×-9.3×
P/S16.8×-0.6×

Profitability

See full
Gross margin100%—
Net margin64.1%+14.9pp
FCF margin82.3%-0.1pp

Returns & leverage

See full
Return on equity9.5%+2.4pp
Debt / equity0.2×-0.1×

Where this comes from

Reported directly by CareTrust in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: CareTrust’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareTrust's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareTrust's stock issuance proceeds?
CareTrust (CTRE) reported stock issuance proceeds of $127.9M in Q1 2026.
How has CareTrust's stock issuance proceeds changed year-over-year?
CareTrust's stock issuance proceeds increased by 721.9% year-over-year, from $15.56M to $127.9M.
What is the long-term trend for CareTrust's stock issuance proceeds?
Over 3 years (2022 to 2025), CareTrust's stock issuance proceeds has grown at a 183.1% compound annual growth rate (CAGR), from $47.24M to $1.07B.
What does stock issuance proceeds mean?
Cash inflows resulting from the sale of common equity shares to investors, typically used to fund acquisitions or strengthen the balance sheet. This metric highlights the company's reliance on equity markets for capital.